← All organizations

GMP BIO Co., LTD.

For profitWebsite ↗

Also known as: Director | GMP BIO Co., LTD.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Last known activity

Nov 1, 2023

Timeline

2000s

Jan 1, 2000
GMP BIO Co., LTD.— Founded

Drugs by trial phase (17 distinct, 14 trials)

Phase 4 (1 own, 0 via acquisition)

triamcinolone

Phase 3 (1 own, 0 via acquisition)

house dust mite allergen

Phase 2 (11 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

xenon-129

Other trials (3 own, 0 via acquisition)

Indications

Studied for

Recent trials (16)

NCT06080100Study directorEarly Phase 1Nov 1, 2023
NCT05997238OfficialPhase 4Apr 25, 2023
NCT05570383Study directorPhase 2/Phase 3Dec 1, 2022
NCT05570383OfficialPhase 2/Phase 3Dec 1, 2022
NCT05613842Overall official - principal investigatorPhase 2Aug 9, 2022
NCT04739917Overall official - principal investigatorPhase 2Jun 1, 2021
NCT04525638Study directorPhase 2Jun 29, 2020
NCT04420299Study directorPhase 2Jun 4, 2020
NCT05168085Overall official - principal investigatorN/AFeb 13, 2020
NCT04206943Study directorPhase 1/Phase 2Oct 12, 2019
NCT03865017Lead sponsorPhase 1/Phase 2Jun 21, 2019
NCT03865017Study directorPhase 1/Phase 2Jun 21, 2019
NCT04010552Study directorPhase 2May 1, 2019
NCT04009876Study directorPhase 2May 1, 2019
NCT04700930Overall official - principal investigatorN/AOct 4, 2018

Details

Founded: Gwangju, KR Jan 1, 2000
Last known activity: Nov 1, 2023